Clinical Trial Update: Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on ultrasound accelerated thrombolysis for submassive and massive pulmonary embolism has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Massive Pulmonary Embolism
• Pulmonary Embolism
• Pulmonary Thromboembolism
• Sub-massive Pulmonary Embolism

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Pulmonary Embolism, Acute Pulmonary Embolism | Phase 3 | Status: COMPLETED | Results posted: 2019-07-05